Home

Chimeric Therapeutics (ASX:CHM) - Webinar Presentation

PUBLISHED

2024-03-01

Content


Jennifer Chow - CEO & Managing Director - Chimeric Therapeutics (ASX:CHM) is a clinical-stage cell therapy company focused on bringing the promise of cell therapy to life for more patients with cancer.

Author

Name Finance News Network